Caroline Litchfield serves as the Executive Vice President and Chief Financial Officer at Merck & Co., Inc., a leading global biopharmaceutical company. In her role, she is responsible for overseeing the company's global financial operations, including financial planning and analysis, accounting, tax, and investor relations. Litchfield plays a critical role in shaping Merck's financial strategy and ensuring the company's long-term growth and sustainability. Prior to joining Merck in 2013, Litchfield had an impressive career in the finance industry. She spent over two decades at General Electric (GE), where she held various leadership positions, including Chief Financial Officer of GE Healthcare Systems and Vice President of Financial Planning and Analysis for GE's Healthcare division. During her tenure at GE, Litchfield was instrumental in driving the company's financial performance and implementing strategic initiatives that contributed to its success. Since joining Merck, Litchfield has been recognized for her exceptional leadership and contributions to the company's financial success. Under her guidance, Merck has maintained a strong financial position, enabling the company to invest in research and development, pursue strategic acquisitions, and deliver value to shareholders. Litchfield's expertise and strategic vision have been instrumental in positioning Merck as a leader in the biopharmaceutical industry, and her role as CFO continues to be vital to the company's ongoing success.